77% reduction in rate of progression - what is the 'average' time for progression from intermediate to late stage ? i.e. what is the 'average' time delay from intermediate to late stage for the 'average' patient receiving 2RT treatments ? & I guess also how many treatments at what cost ?
Lots of details to come out but their will be plenty of people willing to play the % game & try to delay AMD onset with 2RT treatments.
Pay per treatment. I was hoping this would be a revenue model as just selling the 2RT lasers would be a poor outcome.
.
Ann: ELX LEAD Clinical trial results, page-5
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.0¢ |
Change
-0.010(4.35%) |
Mkt cap ! $50.34M | |||
| Open | High | Low | Value | Volume |
| 24.0¢ | 24.0¢ | 22.0¢ | $170.5K | 753.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 264524 | 22.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.5¢ | 63154 | 2 |
View Market Depth
| Last trade - 16.10pm 07/06/2024 (20 minute delay) ? |
|
|||||
|
Last
22.0¢ |
Change
-0.010 ( 6.38 %) |
||||
| Open | High | Low | Volume | ||
| 23.0¢ | 23.5¢ | 22.0¢ | 293179 | ||
| Last updated 15.58pm 07/06/2024 ? | |||||
| EYE (ASX) Chart |